English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [999]
News [2139]
Articles [119]
Editorials [8]
Conferences [84]
elearning [10]
CG0070 plus pembro shows promising efficacy in NMIBC unresponsive to BCG
Dr Roger Li - Moffitt Cancer Center, Tampa, USA
CG0070 plus pembro shows promising efficacy in NMIBC unresponsive to BCG ( Dr Roger Li - Moffitt Cancer Center, Tampa, USA )
22 Mar 2023
ASCO GU 2023: Prostate QoL data and apalutamide plus active surveillance
Prof Heather Payne and Dr Jochen Walz
ASCO GU 2023: Prostate QoL data and apalutamide plus active surveillance ( Prof Heather Payne and Dr Jochen Walz )
21 Mar 2023
Time toxicity: opportunity costs of low value cancer treatment
Dr Christopher Booth - Queen's University, Kingston, Canada
Time toxicity: opportunity costs of low value cancer treatment ( Dr Christopher Booth - Queen's University, Kingston, Canada )
20 Mar 2023
Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy...
Dr Renu Eapen - Peter MacCallum Cancer Centre, Melbourne, Australia
Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy in men with HR PC ( Dr Renu Eapen - Peter MacCallum Cancer Centre, Melbourne, Australia )
16 Mar 2023
Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free...
Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany
Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival via PSMA-radioguided surgery ( Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany )
16 Mar 2023
Diagnostic performance of 18F-rhPSMA-7.3 PET in newly diagnosed unfavourable...
Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany
Diagnostic performance of 18F-rhPSMA-7.3 PET in newly diagnosed unfavourable intermediate to very high-risk prostate cancer ( Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany )
16 Mar 2023
Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti...
Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy
Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti-tumour activity ( Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy )
16 Mar 2023
Digital rectal examination is not useful as a solitary screening tool for...
Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
Digital rectal examination is not useful as a solitary screening tool for prostate cancer in young men ( Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany )
16 Mar 2023
Single intensive screening intervention using PSA and Stockholm3 in combination...
Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
Single intensive screening intervention using PSA and Stockholm3 in combination might reduce prostate cancer mortality ( Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany )
16 Mar 2023
Intravesical IO using durvalumab shows promising results for patients with high...
Dr Charalampos Fragkoulis - General Hospital of Athens, Athens, Greece
Intravesical IO using durvalumab shows promising results for patients with high risk NMIBC after BCG failure ( Dr Charalampos Fragkoulis - General Hospital of Athens, Athens, Greece )
16 Mar 2023
Surgical technique remains the most important factor associated with recovery...
Dr Rafael Sanchez-Salas - McGill University Health Center, Montreal, Canada
Surgical technique remains the most important factor associated with recovery of urinary continence after radical prostatectomy ( Dr Rafael Sanchez-Salas - McGill University Health Center, Montreal, Canada )
16 Mar 2023
EAU 2023: Treatment landscape for early-stage bladder cancer
Dr Bernadett Szabados, Prof Rob Jones, Dr Félix Guerrero-Ramos and Dr Cosimo De...
EAU 2023: Treatment landscape for early-stage bladder cancer ( Dr Bernadett Szabados, Prof Rob Jones, Dr Félix Guerrero-Ramos and Dr Cosimo De Nunzio )
16 Mar 2023
<12345...84>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2023 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top